Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-13 4:01 pm Sale | 2024-12-31 | 13G | Talen Energy Corporation TLN | Rubric Capital Management LP | 6,123,500 13.320% | -5,245,114![]() (-46.14%) | Filing History |
2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Rubric Capital Management LP | 2,350,000 7.290% | 1,100,000![]() (+88.00%) | Filing History |
2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | QuidelOrtho Corporation QDEL | Rubric Capital Management LP | 5,550,000 8.250% | 1,350,000![]() (+32.14%) | Filing History |
2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | GoodRx Holdings, Inc. GDRX | Rubric Capital Management LP | 5,804,628 5.570% | 1,124,600![]() (+24.03%) | Filing History |
2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | Schrödinger, Inc. SDGR | Rubric Capital Management LP | 5,000,000 7.850% | 1,314,497![]() (+35.67%) | Filing History |
2025-02-13 4:01 pm Sale | 2024-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rubric Capital Management LP | 4,205,129 4.710% | -821,802![]() (-16.35%) | Filing History |
2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | Seaport Entertainment Group Inc SEG | Rubric Capital Management LP | 573,408 4.510% | 296,466![]() (+107.05%) | Filing History |
2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | Golar LNG Limited GLNG | Rubric Capital Management LP | 7,710,211 7.390% | 1,203,454![]() (+18.50%) | Filing History |
2025-02-13 4:01 pm Sale | 2024-12-31 | 13G | Coherus BioSciences, Inc. CHRS | Rubric Capital Management LP | 5,258,754 4.560% | -5,141,246![]() (-49.44%) | Filing History |
2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | New Fortress Energy Inc. NFE | Rubric Capital Management LP | 15,000,000 5.620% | 15,000,000![]() (New Position) | Filing History |
2025-02-13 4:01 pm Sale | 2024-12-31 | 13G | Pediatrix Medical Group, Inc. MD | Rubric Capital Management LP | 3,148,440 3.670% | -5,126,560![]() (-61.95%) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Rubric Capital Management LP | 10,966,672 9.380% | 4,322,142![]() (+65.05%) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Coherus BioSciences, Inc. CHRS | Rubric Capital Management LP | 10,400,000 9.030% | 10,400,000![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Rubric Capital Management LP | 2,419,103 5.960% | 2,419,103![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Schrödinger, Inc. SDGR | Rubric Capital Management LP | 3,685,503 5.790% | 3,685,503![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Seaport Entertainment Group Inc SEG | Rubric Capital Management LP | 276,942 5.020% | 276,942![]() (New Position) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | Rubric Capital Management LP | 0 0.000% | -3,344,810![]() (Position Closed) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Talen Energy Corporation TLN | Rubric Capital Management LP | 11,368,614 22.290% | 11,368,614![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Rubric Capital Management LP | 14,400,000 9.760% | 14,400,000![]() (New Position) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | ANI Pharmaceuticals, Inc. ANIP | Rubric Capital Management LP | 56,671 0.270% | -1,068,329![]() (-94.96%) | Filing History |